TECX Q3 2020 Earnings — Tectonic Therapeutic, Inc. Revenue & Financial Results | Market Cap Arena

TECXTectonic Therapeutic, Inc.

$634M

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$314,000

Operating Income

-$37M

Net Income

-$37M

EPS (Diluted)

$-12.11

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$25M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$233M

Total Liabilities

$25M

Stockholders' Equity

$208M

Cash & Equivalents

$220M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$314,000	-$215,000	-46.0%
Operating Income	-$37M	-$18M	-103.3%
Net Income	-$37M	-$17M	-114.5%